tirzepatide and bone loss Tirzepatide: a novel therapeutic approach for Alzheimer's disease | Metabolic Brain Disease GLP-1 Therapy After 65: Benefits,

In addition, in rare cases, Jardiance can cause high blood pressure and kidney issues

Keep that mental scoreboard handy

Weight loss: In a phase 3 clinical trial , people with obesity taking tirzepatide lost an average of 15%21% of their body weight over 72 weeks (about a year and five months)

The Reason for Compassionate Use Compassionate use, or expanded access, exists for a reason

It improves cardiac function in rats and humans with chronic heart failure

Research continues in functional hypothalamic amenorrhea (FHA), a condition where stress, low body weight, or excessive exercise suppresses reproductive function